Delivery Order SPE2DB24D3013-SPE2DB25FFJTF
Award Date
2/24/25
Potential Completion Date
2/25/25
Potential Value
$1.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of QUILLIVANT XR 25 MG/5 ML SUSP 120ML, a prescription medication. The delivery order has a ceiling value of $7,059.83 and a period of performance through February 14, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $4,745.73 and provides for the delivery of 4567025829 - QUILLIVANT XR 25 MG/5 ML SUSP 60ML, a pharmaceutical product. The contract is a firm fixed price arrangement with a performance period ending on January 24, 2025. There is no set-aside designation, indicating this was an...
This is a delivery order awarded under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp's Corporate Office Division with the Defense Logistics Agency (DLA) Troop Support Medical. The IDC, valued up to $999,999,999.00 through December 31, 2025, serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense (DOD) worldwide. The specific delivery...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,698.72, is for the supply of QUILLIVANT XR 25 MG/5 ML SUSP 180ML, a specialty medication. The contract has an ultimate completion date of January 17, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,051.36 firm fixed-price delivery order is for the supply of QUILLIVANT XR 25 MG/5 ML SUSP 60ML, a specialty medication. The contract has an ultimate completion date of December 4, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,040.41 firm fixed price delivery order contract is for the supply of QUILLIVANT XR 25 MG/5 ML SUSP 60ML, a specialty medication. The contract has an ultimate completion date of October 30, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide a specialty medication, QUILLIVANT XR 25 mg/5 ml suspension, 150 ml. The contract has a ceiling value of $2,008.79 and a performance period through April 4, 2024. This delivery order contract is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp by DLA,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,850.42 Firm Fixed Price Delivery Order contract is for the supply of QUILLIVANT XR 25 MG/5 ML SUSP 120ML, a specialty medication. The contract has an ultimate completion date of October 25, 2024. This appears to be a task order issued under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract, valued at $1,016.24, is for the supply of 4565911710 - QUILLIVANT XR 25 MG/5 ML SUSP 60ML, a prescription medication. The contract has a firm-fixed price and an ultimate completion date of September 24, 2024. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of QUILLIVANT XR 25 MG/5 ML SUSP 180ML, a prescription medication. The contract has a ceiling value of $1,499.04 and an ultimate completion date of August 30, 2024. The contract is a Firm Fixed Price, Delivery Order type and does not have a set-aside designation. AmerisourceBergen Drug Corp holds significant Indefinite Delivery...